SOUTH JORDAN, Utah, April 30, 2018 -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate at three conferences in May.
On Wednesday, May 9, at 2:10 p.m. ET, Merit’s Chairman and Chief Executive Officer Fred P. Lampropoulos will present at Deutsche Bank’s 43rd Annual Health Care Conference being held at the Intercontinental Hotel Boston. He will also participate in one-on-one meetings throughout the day.
On Thursday, May 17, at 8:15 a.m. PT, Lampropoulos will present at the Bank of America Merrill Lynch Health Care Conference at The Encore in Las Vegas. He will also participate in one-on-one meetings throughout the day.
On Monday, May 21, at 3:00 p.m. ET, Merit’s Chief Financial Officer Bernard Birkett will present at the UBS Global Healthcare Conference at the Grand Hyatt New York Hotel. He will also participate in one-on-one meetings throughout the day.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 290 individuals. Merit employs approximately 5,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; San Jose, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; and Singapore.
Contact: Anne-Marie Wright, Vice President, Corporate Communications
Phone: (801) 208-4167 e-mail: [email protected] Fax: (801) 253-1688


Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Japan Earthquake Disrupts Auto and Chip Supply Chains
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 



